Moderna stock soars over 90% premarket on first Phase 3 success for mRNA cancer vaccine
Moderna stock soars over 90% premarket on first Phase 3 success for mRNA cancer vaccine
- Read at Crypto Briefing
- Wed, 19 Aug 2026 12:46:49 +0000
Moderna stock soars over 90% premarket on first Phase 3 success for mRNA cancer vaccine